I am grateful for her time & generosity. There is a difference between a supervisor and a mentor, I could talk to my mentor about so many different things and learn from her own journey. Sugandha talking about the benefits of her mentoring experience. #VisionaryLeadership

The science of #immunotherapy can cure a patient's otherwise incurable cancer. But sometimes immunotherapy fails completely Shockingly, we hardly know why. A meta-analysis of #Genomics & #Transcriptomics in >1,000 immunotherapy-treated patients aims to better understand why🧵

Ki Wook Kim 김기욱 What the editorial doesn’t tell you is that ECRs LOVE research - job satisfaction is drowning in anxiety because of insecure employment. Research is a great job as long as you don’t have to worry about your pay/rent/mortgage.

One of the mysteries of public health that I will probably never understand: how can so many people in India have such a raging Vitamin D deficiency when our ☀️🌞 shines so brightly through the year!!

This is a ripe tomato sorting machine 🍅

Hey nature, what do you think of this gem from vol. 248, 26 April 1974? What were you all smoking?

Reading good review articles can shape ideas, help connecting the dots and understanding what’s coming ahead in science. Here’s 10 review articles that helped me shape my views on breast oncology and drug development:

Do you work on DNA repair, telomeres or cell cycle? Are you interested in their roles in development, cancer or other human diseases? Come to Melbourne for our conference! October 23-25. Registrations are now live! #ACDTM23 australiancellcycle.org

Very proud to see our work on the pan-cancer comparison of the genomic landscapes of primary and metastatic tumor published in this weeks issue of Nature: nature.com/articles/s4158…. Francisco Martínez-Jiménez Arne Van Hoeck Hartwig Medical @UMCU_CMM Oncode Institute Vall d’Hebron Institute of Oncology (VHIO)

Just published: Our serendipitous finding that non-cancerous lung epithelial cells spontaneously become mesenchymal-like in 2D and 3D culture without genetic or environmental changes. Work skilfully led by Sugandha. #LungCancer #lcsm #cancerresearch authors.elsevier.com/sd/article/S19…

Fantastic line up of speakers for this, incl. A/Prof Samantha Stehbens PhD, Megan Lord, Lara Perryman, Nicole L Yuwono, Ellie Mok, Kendelle J Murphy, Luke Hipwood and many many more, covering a wide range of matrix biology topics ...

To close 2023, we present our work on #osteosarcoma genome and clonal evolution biorxiv.org/content/10.110… How does #osteosarcoma arise? What rearrangement mechanisms cause some of the most complex #chromothripsis events seen in human cancer? Does chromothripsis occur subclonally?👇

PhD students: it’s a waste to just try to impress your committee at the meeting. Bring them problems, ask for suggestions, and generally think of it as a session in which new ideas can emerge.

New article: 'Targeting chromosomal instability and aneuploidy in cancer', led by Sugandha together with Kum Kum Khanna. TL;DR? See thread below. authors.elsevier.com/a/1ibIsbg0koodT Centre for Cancer Biology UniSA

Elated to see this published. Review article: 'Targeting chromosomal instability and aneuploidy in cancer', in Trends in Pharmacological Sciences together with Pascal Duijf Kum Kum Khanna. authors.elsevier.com/a/1ibIsbg0koodT Centre for Cancer Biology UniSA QUT Centre for Genomics & Personalised Health Translational Research Institute QIMR Berghofer

EMT is a process occurring in cancer metastasis, enabling drug resistance. Sometimes, docetaxel treatment can also promote EMT. TRI-based Rik Thompson and Sugandha from QUT QUT Centre for Genomics & Personalised Health say longer, low-dose docetaxel treatment can block EMT. bit.ly/3SH4KuG

Nice study with #Cameron Evans and #Nicole Smith, UWA.. longer, lower initial doses of Docetaxel could sensitise the tumour cells to other chemotherapies, as noticed for eribulin... QUT Oz MRS TEMTIA TEMTIA Sugandha

Yesterday, we were joined by Donghan (Mo)Yang, PhD on OsteoBites to discuss, "Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research" Watch the full episode here: youtube.com/watch?v=RgF0G2… #MIBAgents #MakeItBetter

Exciting speakers on CIN! Kicking it off: Marcin Imieliński, May 17 9am New York | 2pm London | 3pm Berlin » A mass balance principle for whole genome structural variation « dkfz-de.zoom.us/j/68497535002?…

Excited to organize with Prof. V Mahadevan Inst. of Bioinformatics and Applied Biotechnology a symposium highlighting the women speakers investigating cancer as a complex system. Poster session, panel discussion, hands-on training on AI/ML in genomics too! Registration deadline: June 25. Biopatrika Rakesh Kumar